• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Atlantic Coastal Acquisition Corp. II (Amendment)

    2/14/23 11:45:38 AM ET
    $ACAB
    Blank Checks
    Finance
    Get the next $ACAB alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A MMCAP International Inc. SPC: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)

    Atlantic Coastal Acquisition Corp. II

    (Name of Issuer)


    Series A Common Stock, par value $0.0001

    (Title of Class of Securities)


    04845A108

    (CUSIP Number)


    December 31, 2022

    (Date of Event Which Requires Filing of This Statement)

    Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)


    CUSIP No. 04845A108

     

    Page 2 of 7 Pages


    1

    NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

     

    MMCAP International Inc. SPC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) ☑
    (b) ☐

     


    3

    SEC USE ONLY

     


       

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    750,000*

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    750,000*

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    750,000*

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

    ☐

     


    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.50%**

    12

    TYPE OF REPORTING PERSON

     

    CO


    FOOTNOTES

    * Consist of 750,000 shares of the Issuer’s Series A common stock.

    ** The percentages used herein are calculated based on 30,000,000 shares outstanding of the Issuer as reported in the Issuer’s Form 8-K filed with the Securities and Exchange Commission on November 10, 2022.


    CUSIP No. 04845A108

     

    Page 3 of 7 Pages


    1

    NAME OF REPORTING PERSONS
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

     

    MM Asset Management Inc.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) ☑
    (b) ☐

     


    3

    SEC USE ONLY

     


       

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Ontario, Canada

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    750,000*

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    750,000*

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    750,000*

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

    ☐

     


    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.50%**

    12

    TYPE OF REPORTING PERSON

     

    CO


    FOOTNOTES

    * Consist of 750,000 shares of the Issuer’s Series A common stock.

    ** The percentages used herein are calculated based on 30,000,000 shares outstanding of the Issuer as reported in the Issuer’s Form 8-K filed with the Securities and Exchange Commission on November 10, 2022.


    CUSIP No. 04845A108

     

    Page 4 of 7 Pages

    Item 1 (a). Name of Issuer:

    Atlantic Coastal Acquisition Corp. II

    Item 1 (b). Address of Issuer's Principal Executive Offices:

    6 St. Johns Lane, Floor 5, New York, New York 10013

    Item 2 (a). Name of Person Filing:

    i) MMCAP International Inc. SPC

    ii) MM Asset Management Inc.

    Item 2 (b). Address of Principal Business Office or, if None, Residence:

    i) c/o Mourant Governance Services (Cayman) Limited

    94 Solaris Avenue
    Camana Bay, P.O. Box 1348
    Grand Cayman, KY1-1108, Cayman Islands

    ii) 161 Bay Street

    TD Canada Trust Tower Suite 2240
    Toronto, ON M5J 2S1 Canada

    Item 2 (c). Citizenship:

    i) Cayman Islands
    ii) Ontario, Canada

    Item 2 (d). Title of Class of Securities:

    Series A Common Stock, par value $0.0001

    Item 2 (e). CUSIP Number:

    04845A108

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     (a) ☐ Broker or dealer registered under Section 15 of the Act;

     (b) ☐ Bank as defined in Section 3(a)(6) of the Act;

     (c) ☐ Insurance Company as defined in Section 3(a)(19) of the Act;

     (d) ☐ Investment Company registered under Section 8 of the Investment Company Act;

     (e) ☐ Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     (f) ☐ Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F);

     (g) ☐ Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);

     (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;


    CUSIP No. 04845A108

     

    Page 5 of 7 Pages

     (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment
       Company Act of 1940:

     (j) ☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(j).

     ☒ If this statement is filed pursuant to Rule 13d-1(c), check this box.

    Item 4. Ownership.

     Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

     (a) Amount beneficially owned: 0

     (b) Percent of class:  2.50%**

     (c) Number of shares as to which such person has:

     (i) Sole power to vote or to direct the vote:  0

     (ii) Shared power to vote or to direct the vote:  750,000*

     (iii) Sole power to dispose or to direct the disposition of:  0

     (iv) Shared power to dispose or to direct the disposition of: 750,000*

    * Consist of 750,000 shares of the Issuer's Series A common stock.

    ** The percentages used herein are calculated based on 30,000,000 shares outstanding of the Issuer as reported in the Issuer's Form 8-K filed with the Securities and Exchange Commission on November 10, 2022.

    Instruction.  For computations regarding securities which represent a right to acquire an underlying security, see Rule 13d-3(d)(1).

    Item 5. Ownership of Five Percent or Less of a Class.

     If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ X ].

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     N/A

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     N/A

    Item 8. Identification and Classification of Members of the Group.

     N/A

    Item 9. Notice of Dissolution of Group.

     N/A


    CUSIP No. 04845A108

     

    Page 6 of 7 Pages

    Item 10. Certification.  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    MMCAP International Inc. SPC

     

     

    Date: February 14, 2023

    By: /s/ Ulla Vestergaard ____________

     

          Name: Ulla Vestergaard

          Title: Director

     

     

     

     

     

     

     

    MM Asset Management Inc.

     

     

    Date: February 14, 2023

    By: /s/ Hillel Meltz___________________

     

          Name: Hillel Meltz

          Title: President



    CUSIP No. 04845A108

     

    Page 7 of 7 Pages

    EXHIBIT 1

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

    Dated: February 14, 2023

     

    MMCAP International Inc. SPC

     

     

     

    By: /s/ Ulla Vestergaard ____________

     

          Name: Ulla Vestergaard

          Title: Director

     

     

     

     

     

     

     

    MM Asset Management Inc.

     

     

     

    By: /s/ Hillel Meltz___________________

     

          Name: Hillel Meltz

          Title: President



    Get the next $ACAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACAB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ACAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Atlantic Coastal Acquisition Corp. II (Amendment)

      SC 13G/A - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

      2/7/24 1:53:24 PM ET
      $ACAB
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by Atlantic Coastal Acquisition Corp. II (Amendment)

      SC 13G/A - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

      1/19/24 4:17:41 PM ET
      $ACAB
      Blank Checks
      Finance
    • SEC Form SC 13D filed by Atlantic Coastal Acquisition Corp. II

      SC 13D - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

      4/20/23 6:01:50 AM ET
      $ACAB
      Blank Checks
      Finance

    $ACAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Abpro Bio International, Inc. claimed ownership of 16,507,334 shares (SEC Form 3)

      3 - Abpro Holdings, Inc. (0001893219) (Issuer)

      11/18/24 9:00:34 PM ET
      $ACAB
      Blank Checks
      Finance
    • SEC Form 3 filed by new insider Mcdonald Ian

      3 - Abpro Holdings, Inc. (0001893219) (Issuer)

      11/18/24 8:52:41 PM ET
      $ACAB
      Blank Checks
      Finance
    • Co-CEO & Chairman Suk Jin Wook (Miles) was granted 91,900 shares (SEC Form 4)

      4 - Abpro Holdings, Inc. (0001893219) (Issuer)

      11/15/24 9:34:52 PM ET
      $ACAB
      Blank Checks
      Finance

    $ACAB
    SEC Filings

    See more

    $ACAB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SEC Form NT 10-Q filed by Atlantic Coastal Acquisition Corp. II

      NT 10-Q - Abpro Holdings, Inc. (0001893219) (Filer)

      11/15/24 4:05:03 PM ET
      $ACAB
      Blank Checks
      Finance
    • Atlantic Coastal Acquisition Corp. II filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Abpro Holdings, Inc. (0001893219) (Filer)

      11/13/24 5:21:02 PM ET
      $ACAB
      Blank Checks
      Finance
    • SEC Form 25-NSE filed by Atlantic Coastal Acquisition Corp. II

      25-NSE - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

      11/12/24 4:31:03 PM ET
      $ACAB
      Blank Checks
      Finance
    • Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

      NEW YORK, June 13, 2024 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ:ACAB) (the "Company"), a special purpose acquisition company, announced that it had previously received written notification (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on June 3, 2024 that, because the Company had not yet filed its Quarterly Report on Form 10-Q for the three month period ended March 31, 2024 (the "10-Q") with the Securities and Exchange Commission (the "SEC"), the Company was not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1). The Notice has no immediate effect on the listing of the Company

      6/13/24 4:15:00 PM ET
      $ACAB
      Blank Checks
      Finance
    • Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

      WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation ("Abpro"), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACAB), a special purpose acquisition company ("Atlantic Coastal"), today announced the filing of a registration statement on Form S-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") on January 19, 2024, which includes a preliminary proxy statement and prospectus in connection with its proposed business combination. Upon the closing of the proposed business

      1/22/24 8:00:00 AM ET
      $ACAB
      Blank Checks
      Finance
    • Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II

      Abpro is a biotechnology company specializing in the development of next-generation antibody therapies intended to improve the lives of those with life-threatening diseases. The transaction values Abpro at $725 million and will help advance Abpro's drug pipeline to clinical trials. Abpro Corporation ("Abpro"), a biotechnology company with the mission of improving the lives of those facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACAB), a special purpose acquisition corporation ("Atlantic Costal"), today announced a term sheet to enter into a definitive business combination, which was entered into o

      9/21/23 4:00:00 PM ET
      $ACAB
      Blank Checks
      Finance